Bayer Stock on the Verge of Breakthrough?

10/4/2025, 10:00 AM

The long suffering of Bayer shareholders could soon come to an end: New medications, positive court rulings, and an exciting technical chart setup indicate a possible trend reversal – and could finally free the stock from its years-long sideways corridor.

Eulerpool News Oct 4, 2025, 10:00 AM

Blockbuster in the Pipeline: Hopefuls Bemdaneprocel and Elinzanetant

Legacy issues fade: Glyphosate lawsuits on the home stretch

Chart technology promises potential – 40 euros in sight

Discover undervalued stocks with Eulerpool.

News